Back to Search Start Over

Genetic profiling of breast cancer: A case study on Wnt and BRCA pathways.

Authors :
Listyorini, Dwi
Wisnubroto, Justinus Dwi Pratjojo
Akhsan, Alfiyannul
Tanggo, Vidi Vianney Chrisana Magrit
Ardana, I. Kade Karisma Gita
Wardana, Zefry Okta
Ariyadhiny, Marelda
Nisa', Silmy Rufiatin
Shima, Elya Khunazatus
Praseptin, Patricia Karin Himawan
Pangesti, Delia Wahyu
Sabatia, Annasa
Susanto, Hendra
Handayani, Nursasi
Saragih, Hendri Trisakti
Ilmi, Miftahul
Nopitasari, Sri
Audinah, Liya
Widyasari, Annisaa
Sari, Mutiara Arum
Source :
AIP Conference Proceedings; 2020, Vol. 2260 Issue 1, p1-7, 7p
Publication Year :
2020

Abstract

Breast cancer prevalence tends to increase by the time estimated at ± 1,050,346 cases yearly. There are reports of genetic factors as the main reasons, yet there is poor information on this aspect in Indonesia. Wnt and BRCA pathways had been understood to regulate the development of breast cancer. The mutation of BRCA family members had been found in many breast cancers cases. Meanwhile, Wnt family demostrate its two faces. Some canonical Wnt members are playing on promoting tumorigenesis, while some non-canonical Wnts antagonizing the canonical one. This study aimed to unveil the genetic profile of breast cancer tissue isolated from East Javan patients in Indonesia with focus on Wnt and BRCA pathways. Furthermore, we seek the possible role of mainly Wnts and BRCA family members genes in breast cancer cases found in East Java. Total RNA of stages III and IV fresh biopsy samples from five patients were isolated and reverse-transcripted into cDNA. The expression Wnt4, Wnt5a, BRCA2, and TP53 were analyzed using relative q- PCR with standardized OneWay ANOVA. This study revealed that TP53, BRCA2, were expressed highly in earlier stage (stage IIIB) along with Wnt4, while Wnt5a was highly expressed in later stage (stage IV). From this study we conclude that Wnt4 was supposed to be responsible for earlier cancer development, while Wnt5a was supposed to be responsible for later development. We also suggested that both TP53 and BRCA2 might bear some mutations Currently, we are working on this matter. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
0094243X
Volume :
2260
Issue :
1
Database :
Complementary Index
Journal :
AIP Conference Proceedings
Publication Type :
Conference
Accession number :
145933296
Full Text :
https://doi.org/10.1063/5.0015776